250+ investors that invest in your industry and stage
Any industry
Energy
Proptech
Community
Health Care
Gaming
Artificial Intelligence
Climate
Biotech
Impact
Google
EdTech
Sustainability
Venture Capital
Clean Energy
Finance
Digital Media
Local
Enterprise Software
Email
Travel
Recruiting
Platforms
Fitness
Wine and Spirits
Crowdfunding
Social
CleanTech
Mobile Apps
InsurTech
LGBT
Retail
Infrastructure
Oil and Gas
Fashion
Theatre
Non Profit
SaaS
Renewable Energy
Sporting Goods
Celebrity
Social Impact
Restaurants
Cryptocurrency
Machine Learning
Agriculture (AgTech)
Media (Entertainment)
Facebook
Publishing
Blockchain
Beauty
Real Estate
Life Science
B2B
Film
Web3
Big Data
Organic Food
Video Games
Medical Device
Medical
Wellness
Education
Payments
Art
Social Media
Photography
Music
Franchise
Android
Mobile
Internet
Legal
Construction
eSports
Manufacturing
Sports
Automotive
Hospitality
Financial Services
Mobile Advertising
Cannabis
Biotechnology
FinTech
Consumer
Marketplace
Hardware
Transportation
Food and Beverage
Social Network
Enterprise
Software
Any country
Australia
South Korea
Europe
Brazil
Indonesia
Singapore
Saudi Arabia
Africa
Oceania
LATAM
Asia
Middle East
Costa Rica
Gibraltar
Bahrain
Greece
Finland
Algeria
Liberia
Mexico
Lebanon
Norway
Mauritius
Italy
Israel
Taiwan
Tunisia
Zambia
Nigeria
Russian Federation
Tajikistan
Sweden
Zimbabwe
Togo
Puerto Rico
San Marino
Jamaica
Honduras
Isle of Man
Mozambique
Luxembourg
Albania
Pakistan
Romania
Bangladesh
Kazakhstan
Kenya
Cayman Islands
Cambodia
Oman
Colombia
Cameroon
Guatemala
Seychelles
Ireland
China
Japan
Qatar
South Africa
Spain
Sri Lanka
Armenia
Azerbaijan
Austria
Barbados
Argentina
Vietnam
United Arab Emirates
Bulgaria
Belarus
Estonia
Belgium
Bermuda
Bolivia
Egypt
France
Bahamas
Czech Republic
Chile
Denmark
Faroe Islands
Georgia
Ecuador
Belize
Croatia
Dominican Republic
Hong Kong
Switzerland
Ethiopia
Grenada
Ghana
Iraq
Hungary
Iceland
Jersey
Jordan
Kuwait
Liechtenstein
Lithuania
Morocco
Latvia
Mali
Marshall Islands
Myanmar
Malta
Malaysia
Nicaragua
Namibia
Peru
Philippines
Poland
Panama
Portugal
Rwanda
Sierra Leone
Serbia
Slovenia
Senegal
El Salvador
Thailand
Tanzania
Uruguay
Turkey
Ukraine
Uganda
Uzbekistan
Venezuela
New Zealand
United States
Cyprus
India
Germany
Canada
United Kingdom
Angel Investors
VC Funds
All Investors
Download Find emails Save list

Top 50 Medical Startup Investors in Europe (June 2026)

The most active venture capital funds and angel investors investing in Europe Medical startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Europe Medical startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Bpifrance
VC Fund
52 France, United States, Switzerland Seed, Series A Software, Information Technology, Health Care $658k–$35M
SOSV
VC Fund
33 United States, India, United Kingdom Seed, Convertible Note, Pre-Seed Biotechnology, Health Care, Software
Enterprise Ireland
VC Fund
29 Ireland, United States, United Kingdom Seed, Series A Software, Information Technology, Health Care $439k–$12M
HTGF (High-Tech Gruenderfonds)
VC Fund
25 Germany, Switzerland, United States Seed, Series A Software, Biotechnology, Information Technology $909k–$33M
Parkwalk Advisors
VC Fund
24 United Kingdom, United States, Philippines Seed, Series A, Series B Biotechnology, Health Care, Software $982k–$46M
Scottish Enterprise
VC Fund
23 United Kingdom, United States, Japan Seed, Grant Biotechnology, Software, Health Care $104k–$4.1M
UK Innovation & Science Seed Fund
VC Fund
22 United Kingdom, United States Seed, Series A Biotechnology, Health Care, Medical $393k–$14M
Deepbridge Capital
VC Fund
21 United Kingdom, Australia, Singapore Seed, Series A Health Care, Biotechnology, Medical $152k–$15M
Sofinnova Partners
VC Fund
19 France, United States, United Kingdom Series A, Series B, Series C Biotechnology, Health Care, Medical $6M–$102M
Novo Holdings
VC Fund
19 United States, Denmark, United Kingdom Series A, Series B, Series C Biotechnology, Health Care, Medical $8M–$125M
Oxford Science Enterprises
VC Fund
18 United Kingdom, United States, Finland Seed, Series A, Series B Health Care, Biotechnology, Software $1.3M–$168M
Kurma Partners
VC Fund
17 France, Switzerland, Spain Series A, Seed, Series B Health Care, Biotechnology, Medical $2.3M–$80M
Archangels
VC Fund
16 United Kingdom, United States Seed, Series A Software, Biotechnology, Health Care $1.3M–$8.3M
Oxford Technology Management
VC Fund
15 United Kingdom, United States Seed, Series A Biotechnology, Health Care, Software $33k–$7.9M
Forbion Capital Partners
VC Fund
14 United States, United Kingdom, The Netherlands Series B, Series A, Series C Biotechnology, Health Care, Medical $12M–$176M
Speedinvest
VC Fund
14 Germany, United Kingdom, Austria Seed, Series A, Pre-Seed Software, FinTech, Financial Services $406k–$38M
BioInnovation Institute
VC Fund
14 Denmark, Germany, Switzerland Convertible Note, Pre-Seed, Debt Financing Biotechnology, Medical, Health Care $516k–$5.2M
Idinvest Partners
VC Fund
14 France, United States, Spain Series B, Series A Biotechnology, Health Care, Software $3.3M–$66M
Scottish Investment Bank
VC Fund
14 United Kingdom, United States, France Seed, Series A Software, Biotechnology, Health Care $327k–$7M
Bayern Kapital
VC Fund
14 Germany, United States, Finland Seed, Series A Software, Health Care, Information Technology $1.1M–$31M
GM&C Life Sciences Fund
VC Fund
13 United Kingdom, Italy, Germany Seed, Series A Health Care, Biotechnology, Medical $65k–$4.1M
Mercia Fund Managers
VC Fund
13 United Kingdom, United States, Hungary Seed, Series A Software, Health Care, Biotechnology $196k–$14M
Karista
VC Fund
13 France, United States, Finland Seed, Series A, Series B Software, Biotechnology, Health Care $713k–$43M
Almi Invest
VC Fund
13 Sweden, United States, Ukraine Seed, Pre-Seed Software, Health Care, Information Technology $174k–$2.2M
M Ventures
VC Fund
12 United States, United Kingdom, Switzerland Series A, Series B, Seed Biotechnology, Health Care, Therapeutics $2.4M–$100M
Jonathan Milner
Angel
12 United Kingdom, United States, Spain Seed, Series A, Series B Biotechnology, Health Care, Medical $537k–$56M
Wellcome Trust
VC Fund
12 United States, United Kingdom, France Grant, Series C Biotechnology, Health Care, Medical $1.3M–$127M
Cambridge Innovation Capital
VC Fund
12 United Kingdom, United States, Ireland Series A, Series B, Seed Biotechnology, Health Care, Therapeutics $2M–$73M
Northstar Ventures
VC Fund
12 United Kingdom, United States, Indonesia Seed, Series A Software, Health Care, E-Commerce $39k–$9.7M
Development Bank of Wales
VC Fund
12 United Kingdom, Australia, United States Seed, Debt Financing Software, Health Care, Biotechnology $18k–$3.7M
Wellington Partners
VC Fund
12 Germany, United States, United Kingdom Series A, Series B Health Care, Biotechnology, Medical $3.1M–$55M
KfW
VC Fund
11 Germany, India, Kenya Series A, Series B Biotechnology, Software, Health Care $2.2M–$17M
Chalmers Ventures AB
VC Fund
11 Sweden Pre-Seed, Seed Software, Biotechnology, Health Care $5k–$2.7M
Catapult Ventures
VC Fund
11 United Kingdom, United States, Israel Seed, Series A Health Care, Biotechnology, Medical $150k–$26M
CDP Venture Capital
VC Fund
11 Italy, United States, United Kingdom Seed, Series A Software, Information Technology, Health Care $488k–$17M
Seventure Partners
VC Fund
10 France, United States, Germany Series A, Series B Biotechnology, Software, Health Care $3.1M–$65M
Oxford Capital
VC Fund
10 United Kingdom, United States, France Seed, Series A Software, Health Care, Biotechnology
European Investment Bank
VC Fund
10 France, Germany, The Netherlands Debt Financing, Post-IPO Debt Biotechnology, Health Care, Energy $7.7M–$658M
Calm/Storm VC
VC Fund
10 United Kingdom, Germany, Austria Seed, Pre-Seed, Series A Health Care, Wellness, Software $478k–$18M
Western Development Commission
VC Fund
10 Ireland, United States Seed, Series A Health Care, Medical Device, Biotechnology $642k–$11M
MIG Capital
VC Fund
10 Germany, France, Austria Series A, Series B Biotechnology, Health Care, Therapeutics $1.6M–$54M
GO CAPITAL
VC Fund
10 France, Canada, Israel Seed, Series A Biotechnology, Software, Health Care $516k–$10M
AlbionVC
VC Fund
10 United Kingdom, United States, France Series A, Seed Software, Information Technology, Health Care $2.2M–$20M
APEX Ventures
VC Fund
10 Germany, United Kingdom, Austria Seed, Series A, Pre-Seed Artificial Intelligence, Software, Health Care $511k–$28M
Newable Private Investing
VC Fund
10 United Kingdom, United States Seed, Series A Software, Health Care, Biotechnology $196k–$5.2M
Meusinvest (Noshaq)
VC Fund
10 Belgium, France, Germany Series A, Seed Biotechnology, Health Care, Medical $137k–$16M
Atlantic Bridge
VC Fund
10 United States, Ireland, United Kingdom Series A, Series B Software, Artificial Intelligence, Analytics $4.5M–$62M
Portugal Ventures
VC Fund
9 Portugal, United States, France Seed, Pre-Seed Software, Information Technology, Health Care
Italian Angels for Growth
VC Fund
9 Italy, United States, United Kingdom Seed, Angel, Series A Software, E-Commerce, Health Care
Vesalius Biocapital Partners
VC Fund
9 Belgium, Germany, France Series A, Series B, Series C Biotechnology, Health Care, Medical $3.8M–$100M
Access all 50 investors in Europe Medical startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Bpifrance
VC Fund · Maisons-alfort, Ile-de-France, France · 52 investments in Europe Medical startups

Bpifrance provides financial solutions for companies that are booting up the listing on the stock exchange and credit equity. It includes OSEO, CDC Entreprises, FSI, and FSI Regions to offer in your area of financial solutions at every stage of the life of your business.

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Seed, Series A
  • Geography: France, United States, Switzerland

Investor stats

  • Total investments: 988
  • Round size: Seed $658k–$6.4M; Series A $2.5M–$35M
  • Lead/follow: 22% lead, 78% follow
  • Last fund: Likely actively investing — fund raised in 2025

Portfolio highlights

  • May Health — May Health is developing a modern treatment - Ovarian Rebalancing - designed to restore ovulation for people with polycystic ovary syndrome.
  • Callyope — Callyope is building the first speech-based foundational model to monitor mental health symptoms through low-touch smartphone interactions.
  • Smile Wanted Group — Spot the most valuable inventory on premium websites and provide guarantees of performance to advertisers. Reach +500M users /month globally.
Show all investments...

SOSV
VC Fund · Princeton, New Jersey, United States · 33 investments in Europe Medical startups, 75 in the past 12 months

SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Convertible Note, Pre-Seed
  • Geography: United States, India, United Kingdom

Investor stats

  • Total investments: 1482
  • Lead/follow: no public data

Portfolio highlights

  • MixRift — MIXRIFT - game developers specialized in Mixed Reality
  • unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
  • Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
Show all investments...

Enterprise Ireland
VC Fund · Dublin, Dublin, Ireland · 29 investments in Europe Medical startups

Enterprise Ireland is the government agency responsible for the development and funding of the indigenous business sector. Their mission is to accelerate the development of companies to achieve strong positions in global markets resulting in increased national and regional prosperity. It was founded in 1998 and headquartered in Dublin, Ireland.

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Seed, Series A
  • Geography: Ireland, United States, United Kingdom

Investor stats

  • Total investments: 485
  • Round size: Seed $439k–$3.3M; Series A $2.2M–$12M
  • Lead/follow: 19% lead, 81% follow
  • Last fund: May invest from a new fund soon — raised $1.1M in 2021

Portfolio highlights

  • Tirlan — Tirlan is an agricultural company that supplies agri-food and farm input materials to the framing sector.
  • Lakeland Dairies — Lakeland Dairies, a major dairy processing co-operative, operates within a fifteen county catchment area across the northern half of the island of Ireland. The Group processes about one billion litres of quality milk annually into a range of value added dairy foodservice products and functional dairy food ingredients.
  • Touchtech Payments — At Touchtech Payments, believe in making industry changing and innovative technology.
Show all investments...

HTGF (High-Tech Gruenderfonds)
VC Fund · Bonn, Nordrhein-Westfalen, Germany · 25 investments in Europe Medical startups

High-Tech Grunderfonds finances startups with growth potential. Its team of investment managers supports young companies with expertise, entrepreneurial spirit, and passion. The company focuses in the fields of digital tech, industrial tech, life sciences, chemistry, and related business areas. It also focuses on financial services in varioussectors.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Information Technology
  • Stage:Seed, Series A
  • Geography: Germany, Switzerland, United States

Investor stats

  • Total investments: 542
  • Round size: Seed $909k–$6.5M; Series A $3M–$33M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: Likely still investing — raised $522M in 2022

Portfolio highlights

  • Sdui — Sdui is the solution for mobile communication in schools. With amazingly easy features for messaging, timetables and a wide range of third party integrations, the app digitizes processes and reduces administrative effort. Within two years, Sdui has reached hundreds of institutions and grown a serious reputation in the educational market.
  • envelio — We are driving forward the energy transition with our smart grid solutions for grid operators. Get information now and plan smart!
  • Atriva Therapeutics — Therapies against viral infections. First-in-class host-targeting therapies to treat respiratory viral infections, including COVID-19 and influenza.
Show all investments...

Parkwalk Advisors
VC Fund · London, England, United Kingdom · 24 investments in Europe Medical startups

Parkwalk is a London-based fund management firm. Parkwalk invests in UK technology companies that have IP backing and freedom to operate, generally spun out of UK universities. Their funds seek to generate capital gains for their investors, enhanced by the attractive tax relief provided by EIS. Parkwalk entered this investment sector in 2009,anticipating a wave of tax-efficient incentives launched by the UK Government to stimulate innovative emerging technology companies and thereby help drive economic growth.Parkwalk utilises academic, technology transfer, venture capital and personal networks developed over many years to gain access to the highest calibre deal-flow. In 2017 Parkwalk joined forces with IP Group plc, a leading intellectual property commercialisation company that is listed on the Main Market of the London Stock Exchange under the ticker symbol IPO. As at March 2019 the combined group has net assets of £1.2bn.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Series A, Series B
  • Geography: United Kingdom, United States, Philippines

Investor stats

  • Total investments: 255
  • Round size: Seed $982k–$4.7M; Series A $1.6M–$13M; Series B $2M–$46M
  • Lead/follow: 29% lead, 71% follow
  • Last fund: Likely still investing — fund raised in 2024

Portfolio highlights

  • Nozzle.ai — Award-winning Amazon analytics tools designed to provide FBA Amazon Sellers with unique customer insights. Try for Free.
  • Phasecraft — Using disruptive theory to unlock the power of quantum computing
  • Echion Technologies — Echion Technologies is a spinout from the University of Cambridge Engineering Department, using proprietary battery active materials to develop next-generation Li-ion batteries.
Show all investments...

Scottish Enterprise
VC Fund · Glasgow, Glasgow City, United Kingdom · 23 investments in Europe Medical startups

Scotland's business advice, support and funding agency. Explore our products and services to find the right support for your business and apply online today.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Health Care
  • Stage:Seed, Grant
  • Geography: United Kingdom, United States, Japan

Investor stats

  • Total investments: 285
  • Round size: Seed $300k–$3.4M; Grant $104k–$4.1M
  • Lead/follow: 33% lead, 67% follow

Portfolio highlights

  • TileBio
  • Sentinel
  • Orbital Marine Power — Orbital Marine Power is an innovative Scottish engineering company focused on the development of a low-cost, predictable, scalable floating tidal technology.
Show all investments...

UK Innovation & Science Seed Fund
VC Fund · Harwell, Oxfordshire, United Kingdom · 22 investments in Europe Medical startups

UKI2S, formally the Rainbow Seed Fund, is an investment fund backed by the government, providing seed funding to science & technology start-ups and SMEs

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States

Investor stats

  • Total investments: 130
  • Round size: Seed $393k–$5.9M; Series A $2.9M–$14M
  • Lead/follow: 33% lead, 67% follow
  • Last fund: May invest from a new fund soon — last raise in 2014

Portfolio highlights

  • NanoSyrinx — NanoSyrinx is an award-winning, discovery stage biotechnology company based in the UK. We are using synthetic biology approaches to develop protein nanosyringes as a completely novel modality for intracellular delivery of protein and peptide biologic drugs.
  • Presymptom Health — Enabling Early Diagnosis for better infection & sepsis care. With faster, more accurate testing. Presymptom Health is a medtech company developing a portfolio of patented diagnostic tests that are both faster and more reliable than those available today. Accelerate diagnosis. Address antimicrobial resistance.
  • Pencil Biosciences — Pencil Biosciences is pioneering the next generation of gene editing. We are developing a fully synthetic, RNA-guided platform designed to overcome the limitations of current technologies.
Show all investments...

Deepbridge Capital
VC Fund · Chester, Cheshire, United Kingdom · 21 investments in Europe Medical startups

Deepbridge is a different kind of investment manager. They work closely with financial advisers and investors to design innovative products, ranging from investment in technology growth companies to asset-backed renewable energy projects. They also partner with innovative and committed management teams to help UK based companies realise theirpotential and become successful leading-edge businesses.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Seed, Series A
  • Geography: United Kingdom, Australia, Singapore

Investor stats

  • Total investments: 82
  • Round size: Seed $152k–$2.6M; Series A $2M–$15M
  • Lead/follow: 74% lead, 26% follow
  • Last fund: Likely still investing — raised $1.4M in 2022

Portfolio highlights

  • upLYFT — upLYFT is working on the next generation of smart wearables to help with musculoskeletal issues related to aging. Also working with pro athletes to help sporting individuals train harder and break records.
  • GeneralPractice.AI — General Practice. AI is an advanced, AI-powered platform designed to transform primary care and general practice by streamlining clinical workflows, enhancing patient engagement, and reducing administrative burdens for healthcare professionals. It aims to revolutionize primary care by harnessing artificial intelligence to improve both clinical andadministrative aspects of general practice, ultimately delivering more efficient, personalized, and effective healthcare.
  • Spotlight Pathology — Spotlight Pathology develops decision support tools powered by artificial intelligence (AI) to help in the diagnosis of blood cancers.
Show all investments...

Sofinnova Partners
VC Fund · Paris, Ile-de-France, France · 19 investments in Europe Medical startups

Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: France, United States, United Kingdom

Investor stats

  • Total investments: 298
  • Round size: Series A $6M–$65M; Series B $10M–$102M; Series C $11M–$100M
  • Lead/follow: 46% lead, 54% follow
  • Last fund: Likely still investing — raised $200M in 2023

Portfolio highlights

  • protera — Protera is advancing the science of protein engineering to address some of the most critical problems and opportunities in food, agriculture, the environment and human health. We streamline protein design and development with MADI, our proprietary deep learning algorithm, to predict high value protein products and enzymes with unprecedented speed.Our in-house lab generates small quantities of the new predicted structures to validate their desired performance. Upon lab validation, we collaborate with our clients on next steps to move from pilot to industrial scale production.
  • Bioptimus — Our mission is to build the first universal AI foundation model for biology to fuel breakthrough discoveries and accelerate innovations in biomedicine and beyond.
  • T-Therapeutics — T-Therapeutics is a expertise in mouse genome engineering, deep expertise in biopharmaceutical drug development, single cell genomics, machine-learning and structural biology, anchored in a culture of creativity and collaboration. .
Show all investments...

Novo Holdings
VC Fund · Hellerup, Hovedstaden, Denmark · 19 investments in Europe Medical startups

Novo Holdings is a world-leading life science investor with a focus on creating long-term value.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: United States, Denmark, United Kingdom

Investor stats

  • Total investments: 313
  • Round size: Series A $8M–$100M; Series B $12M–$125M; Series C $30M–$115M
  • Lead/follow: 39% lead, 61% follow
  • Last fund: May invest from a new fund soon — raised $165M in 2018

Portfolio highlights

  • Hillstar Bio — Hillstar Bio is pioneering precision immunotherapies that target and deplete pathogenic immune cells, aiming to reset the immune system and transform treatment for autoimmune diseases.
  • Nkarta Therapeutics — Nkarta seeks to improve upon the efficacy of cell therapy, making it more potent, better tolerated and more rapidly available to a broad population of patients with a variety of hematologic and solid tumor malignancies.While T-cell therapy, often known as CAR-T, has proven successful in certain cancer indications, its promise has been limited toa few hematologic malignancies and the side effects can be severe. Natural Killer cells are the immune system’s first responders against diseases and pathogens. Unlike T cells, they have an inherent ability to target tumor cells without genetic alteration, and therefore hold significant promise in the development of potent therapies that can be used more readily for diverse tumor types. Nkarta’s differentiated cell therapy approach is designed to boost and enhance the inherent power of Natural Killer cells to target and destroy tumor cells, while also offering a better tolerated safety profile.
  • Bolt Biotherapeutics — Bolt is leveraging the immune system for a better way to treat cancer. Our approach works with a person's body, not against it.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Oxford Science Enterprises
VC Fund · Oxford, Oxfordshire, United Kingdom · 18 investments in Europe Medical startups

Oxford Science Enterprises is the university-partnered venture firm. We work with the University of Oxford to build companies that create fundamental technologies: science-based businesses capable of tackling the planet’s toughest problems. We invest in life science, AI and software, healthcare, and deep tech to create companies taking onchallenges like nuclear fusion, quantum computing and developing treatments and cures for infectious diseases. Founded in 2015, we’ve raised over £600M to create a world-class technology ecosystem, and combine our deep experience with a network of investors, entrepreneurs and sector-experts to find co-investment, build businesses, and hire senior management talent.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Software
  • Stage:Seed, Series A, Series B
  • Geography: United Kingdom, United States, Finland

Investor stats

  • Total investments: 161
  • Round size: Seed $1.3M–$10M; Series A $5M–$46M; Series B $8.5M–$168M
  • Lead/follow: 37% lead, 63% follow
  • Last fund: Likely still investing — raised $327M in 2022

Portfolio highlights

  • Mode Labs — Mode Labs provide robust, continuous, and remote real-time chemical sensors.
  • Amber Therapeutics — Developing intelligent bioelectrical therapies that can adapt, respond and learn from each person's individual physiology
  • Pepgen — PepGen empowers nucleic acid therapeutics to go the distance. PepGen's ambition is to unlock the potential of nucleic acid therapeutics by leveraging the drug delivery capabilities of their innovative product engine. PepGen's initial focus is on the application of this technology to the efficacious delivery of antisense oligonucleotides,and they are advancing novel conjugate therapeutics to the clinic.
Show all investments...

Kurma Partners
VC Fund · Paris, Ile-de-France, France · 17 investments in Europe Medical startups

Kurma Partners is a management company based in Paris, specializing in the financing of innovation in healthcare and biotechnology, from pre-creation to development capital. Kurma Partners, which manages the Kurma Biofund I, II funds and the Kurma Diagnostics fund, is one of the main players in the financing of therapeutic and medical innovationsin Europe, particularly through links with many institutes. research and prestigious hospitals.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series A, Seed, Series B
  • Geography: France, Switzerland, Spain

Investor stats

  • Total investments: 128
  • Round size: Seed $2.3M–$13M; Series A $3.8M–$74M; Series B $8.8M–$80M
  • Lead/follow: 50% lead, 50% follow
  • Last fund: Likely actively investing — fund raised in 2024

Portfolio highlights

  • Medlumics — Medlumics is a medical device start-up born in 2009 from a compromise with improving human living standards by means of technology.
  • Vico Therapeutics — Pioneering RNA-based science to target the root cause of rare genetic neurological diseases VO659: The first clinical candidate directly targeting the CAG repea
  • Synendos Therapeutics — Synendos Therapeutics is a biopharmaceutical company that aims to develop breakthrough safe and effective therapies for unmet needs in neuropsychiatric disorders through modulation of a new drug target in the endocannabinoid system that enables restoration of natural functioning of the brain.
Show all investments...

Archangels
VC Fund · Edinburgh, Edinburgh, City of, United Kingdom · 16 investments in Europe Medical startups

Established in 1992. Archangels is the oldest continuously operating business angel syndicate in the World. Investing in IP-rich tech & life sciences companies in Scotland, UK.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Health Care
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States

Investor stats

  • Total investments: 84
  • Round size: Seed $1.3M–$3.9M; Series A $1.6M–$8.3M
  • Lead/follow: 54% lead, 46% follow

Portfolio highlights

  • 1inhaler — 1inhaler operates as a developer of drug delivery device.
  • BioCaptiva — BioCaptiva develops liquid biopsy technology devices to diagnose and monitoring to detect cancers.
  • Administrate — Administrate is a comprehensive, configurable training management platform that helps organizations streamline enterprise learning and development. Organize, deliver, plan, automate, analyze, and scale your training program effectively -- all through one system. Deliver multi-modality learner experiences, maximize training resources, anddemonstrate business results with insight-rich reporting. Hundreds of organizations serving millions of learners choose Administrate to manage their training program.
Show all investments...

Oxford Technology Management
VC Fund · Oxford, Oxfordshire, United Kingdom · 15 investments in Europe Medical startups

Oxford Technology's SEIS fund and EIS fund enable private investors to access high growth technology startup opportunities and support UK innovation. SEIS and EIS tax reliefs offer downside protection, whilst gains can be tax free.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States

Investor stats

  • Total investments: 107
  • Round size: Seed $33k–$2.1M; Series A $786k–$7.9M
  • Lead/follow: 7% lead, 93% follow
  • Last fund: May invest from a new fund soon — last raise in 2012

Portfolio highlights

  • OrganOx — OrganOx Limited was founded in 2008 to exploit normothermic preservation technology invented by Prof Peter Friend and colleagues and further developed by Prof Constantin Coussios at the University of Oxford.
  • CryoLogyx — CryoLogyx Ltd. trading as CryoLogyx registered in England and Wales 13078280. VAT registered 373846855. Our registered office address is CryoLogyx Ltd, The Venture Centre, Sir William Lyons Road, Coventry, CV4 7EZ.
  • Metacarpal — Metacarpal design upper-limb prosthetics without compromise. We aim to make the most robust, functional hand prosthesis that people love wearing because it works so effectively and looks so beautiful. Be proud to show your artificial side!
Show all investments...

Forbion Capital Partners
VC Fund · Naarden, Noord-Holland, The Netherlands · 14 investments in Europe Medical startups

Impacting the future of medicine.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Series A, Series C
  • Geography: United States, United Kingdom, The Netherlands

Investor stats

  • Total investments: 171
  • Round size: Series A $14M–$176M; Series B $12M–$155M; Series C $12M–$113M
  • Lead/follow: 50% lead, 50% follow
  • Last fund: Likely actively investing — fund raised in 2024

Portfolio highlights

  • F2G — F2G is a biopharmaceutical company developing novel therapies for life-threatening fungal infections.
  • Noema Pharma — DRIVING BETTER OUTCOMES Advancing therapeutics designed to deliver superior clinical benefit across both orphan and broader neurology indications Who we are ...
  • Orbis Medicines — Orbis Medicines is a novel macrocyclic chemistry and computational platform for high-throughput drug discovery.
Show all investments...

Speedinvest
VC Fund · Vienna, Wien, Austria · 14 investments in Europe Medical startups

Speedinvest is a globally active European venture capital firm built on a simple belief: many move more. From six offices across EMEA, our sector-focused investment teams back relentless founders from pre–Seed to Growth with long-term conviction, providing day-one access to our global network of corporate customers, experts, industry leaders, andtop-tier follow-on investors to scale smarter and faster. Building lasting companies like Bitpanda (Austria), Moove (Nigeria), Gigs (U.S.), Tide (UK), ARX Robotics (Germany), Wayflyer (Ireland), GoStudent (Austria), Seqera Labs (Spain), and Cylib (Germany) — together. Big ideas may start with one. But scaling and winning take The Power of More.

Show more...

Investment focus

  • Industry: Software, FinTech, Financial Services
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Germany, United Kingdom, Austria

Investor stats

  • Total investments: 518
  • Round size: Seed $823k–$8M; Pre-Seed $406k–$3.8M; Series A $3.7M–$38M
  • Lead/follow: 42% lead, 58% follow
  • Last fund: Likely still investing — raised $384M in 2022

Portfolio highlights

  • Findery — Find and leave notes anywhere in the world, discover local knowledge, hidden secrets, and exciting stories. Share your travel knowledge, geoblog, or local news!
  • MinersAI — Unlock valuable insights from intricate geological data with Miners AI. Our AI-driven platform empowers exploration teams to make informed decisions and optimize mining operations.
  • Primer — Primer is the first open automation platform for payments, enabling you to build end-to-end payment flows with no code, and a checkout developers love.
Show all investments...

BioInnovation Institute
VC Fund · Copenhagen, Hovedstaden, Denmark · 14 investments in Europe Medical startups

BioInnovation Institute is a biotechnology startup that offers entrepreneurs and researchers in life science. Early-stage life science start-ups are supported with up to 10 million DKK in funding, business acceleration, network, labs, and office space. It helps to early-stage start-ups within human health and planetary health. The startup'smission is to use its knowledge, network, funding, and infrastructure to incubate world-class life science and catalyze the commercialization of new solutions through start-ups.BioInnovation Institute was founded in 2018 and is based in Denmark.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Convertible Note, Pre-Seed, Debt Financing
  • Geography: Denmark, Germany, Switzerland

Investor stats

  • Total investments: 72
  • Round size: Pre-Seed $516k–$5.2M; Debt Financing $549k–$1.4M; Convertible Note $549k–$1.5M
  • Lead/follow: 90% lead, 10% follow

Portfolio highlights

  • Zeta Diagnostics — First-in-class hardware-and-software-as-a-service diagnostics for the 400M suffering from middle ear problems
  • Loma Therapeutics — Loma Therapeutics is developing targeted immunotherapy for the effective and safe treatment of HPV infection, dysplasia, and cancer patients.
  • metaLead Therapeutics — metaLead Therapeutics is to develop this peptide as a next-generation Pb poisoning treatment.
Show all investments...

Idinvest Partners
VC Fund · Paris, Ile-de-France, France · 14 investments in Europe Medical startups

Idinvest Partners is a pan-European private equity manager focused on the low and middle-market segments. With over 6 billion euros under management, the company has developed several complementary areas of expertise, including equity investments in buyout deals focusing on both mid-size as well as young innovative European companies; primaryinvestments in European private equity funds focusing primarily on the middle market segment; secondary investments; mezzanine investments in Europe; and private equity consulting.Idinvest Partners’ recent success stories include Criteo, Clear2Pay, Meetic, Prosensa, Converteam, Kwik Fit, Lastminute.com, Dailymotion, Deezer, Talend, Synthesio, Menlook, Vestiaire Collective, Pretty Simple, Curse.com, Withings, Kantox, Secret Escapes, Happn, Peakon, Dayuse, Botify, Financefox, Azalead and many more.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Series B, Series A
  • Geography: France, United States, Spain

Investor stats

  • Total investments: 252
  • Round size: Series A $3.3M–$24M; Series B $7.8M–$66M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: May invest from a new fund soon — raised $88M in 2021

Portfolio highlights

  • Ornikar — Ornikar is an online driving school that offers radically cheaper, uncomplicated and faster offer to obtain a driving license.Ornikar relies on a network of state-qualified teachers to offer an apprenticeship in mobile driving at reduced prices. The cmpany is an an online driving school more in tune with the demand of current and futuregenerations.The company's mission is to make the driver's license exam cheaper and its learning more enjoyable.
  • Glovo — Glovo delivers the best products of your city in less than 1 hour
  • Stanley Robotics — Stanley Robotics is a DeepTech business helping the transportation and logistics industries digitalise and robotise outdoor operations.
Show all investments...

Scottish Investment Bank
VC Fund · Glasgow, Glasgow City, United Kingdom · 14 investments in Europe Medical startups

Speak with our Entrepreneurship and Investment teams, who can help you find sources of finance, engage with funders and secure investment to grow your business.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Health Care
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States, France

Investor stats

  • Total investments: 208
  • Round size: Seed $327k–$3.1M; Series A $1.6M–$7M
  • Lead/follow: 11% lead, 89% follow
  • Last fund: May invest from a new fund soon — last raise in 2015

Portfolio highlights

  • Bio-Images Drug Delivery — BDD Pharma combine drug delivery expertise and clinical capabilities to accelerate product development pipelines, enable life cycle management and new innovative pharmaceutical products. Rapid parallel clinical testing with SWIFT significantly reduces time from product concept to clinical success.
  • IOTech — Discover IOTech Systems. Deploy, manage, and scale AI-driven, data-rich industrial systems at the edge with our open edge data platform.
  • Administrate — Administrate is a comprehensive, configurable training management platform that helps organizations streamline enterprise learning and development. Organize, deliver, plan, automate, analyze, and scale your training program effectively -- all through one system. Deliver multi-modality learner experiences, maximize training resources, anddemonstrate business results with insight-rich reporting. Hundreds of organizations serving millions of learners choose Administrate to manage their training program.
Show all investments...

Bayern Kapital
VC Fund · Landshut, Bayern, Germany · 14 investments in Europe Medical startups

Bayern Kapital (founded at the end of 1995) is a wholly owned subsidiary of the LfA Foerderbank Bayern (Bavaria‘s development bank). Bayern Kapital’s objective is to finance research and development as well as the market launch of new products, product diversifications, and expansion of the market share.The requesting company has to be located inBavaria. Industries are e. g. IT/software, life sciences, new materials, micro-systems and environmental technologies.Bayern Kapital and its funds have invested in more than 250 companies and currently manages funds to the value of EUR 340 m. The five investing funds currently managed by Bayern Kapital are Seedfonds Bayern, Clusterfonds Start-Up!, Innovationsfonds, Innovationsfonds EFRE and Wachstumsfonds Bayern.

Show more...

Investment focus

  • Industry: Software, Health Care, Information Technology
  • Stage:Seed, Series A
  • Geography: Germany, United States, Finland

Investor stats

  • Total investments: 227
  • Round size: Seed $1.1M–$5.5M; Series A $3.9M–$31M
  • Lead/follow: 15% lead, 85% follow
  • Last fund: May invest from a new fund soon — raised $26M in 2010

Portfolio highlights

  • EcoG — EcoG connects and enables monetizing charging infrastructure with an API-software platform. EcoG is the first cloud-based platform to enable shared revenue streams and value-added services in fast charging. With EcoG a personalized and customized EV fast charging experience is easy to implement and operate.
  • XO Life — XO Life is to build the largest real-world evidence platform for patient insights for all medications and therapies. Together with one of Europe's leading research institutes for patient-centered research, the PROMIS Institute Germany of the Charité, and various pharmaceutical manufacturers, patient experiences are to be recorded in astandardized and systematic manner across a wide range of diseases. Patients are to be enabled to record their therapy course and outcome independently as well as scientifically validated so that these patient insights from real treatment practice can be used in the life science industry and by medical professions.
  • inContAlert — inContAlert is a deep tech start-up disrupting the field of incontinence. The technology of inContAlert helps people with bladder dysfunction to monitor the filling level of their urinary bladder.inContAlert, therefore, developed an mHealth device, which collects and analyzes data with the help of deep learning algorithms. The information is thendisplayed on an app and sends an alert to incontinence patients when a predefined filling level is reached. inContAlert thereby minimizes the risk of an uncontrolled loss of urine or the harmful distension of the bladder. With the help of inContAlert, incontinence patients can go back to normal and live a carefree life.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
GM&C Life Sciences Fund
VC Fund · Alderley Edge, Cheshire, United Kingdom · 13 investments in Europe Medical startups

The GM&C Life Sciences Fund is a seed and early stage venture capital fund targeting life sciences businesses located in the Greater Manchester and Cheshire & Warrington region. The Fund is managed by Catapult Venture Managers ("Catapult Ventures").The Fund is based at Alderley Park, which is well recognised as a site ofnational importance, being the largest life sciences campus of its kind in the UK with more than 500,000 sq. ft. of top-end laboratory and related space and facilities. Until recently, the Park was the R&D headquarters for AstraZeneca.Since 2002, Catapult Ventures has backed a significant number of companies across a broad range of life sciences, including therapeutics (such as Abzena and Oxford BioTherapeutics), medical devices (such as Monica Healthcare and Probe Scientific), contract research organisations (such as R5 Pharmaceuticals and FDAS), diagnostics developers (such as Lumora and Biofortuna), as well as developers of technology used in healthcare applications (such as Oxford Cryosystems and Accutronics). The Fund is the result of a collaboration between Cheshire and Warrington Enterprise Partnership, Greater Manchester Combined Authority, Cheshire East Council, and Manchester Science Partnerships.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Seed, Series A
  • Geography: United Kingdom, Italy, Germany

Investor stats

  • Total investments: 33
  • Round size: Seed $65k–$936k; Series A $1.8M–$4.1M
  • Lead/follow: 67% lead, 33% follow

Portfolio highlights

  • Maxwellia — A contraceptive pill, Lovima, is now available to buy without a prescription.
  • Acea Health — Acea Health is a digital healthcare company developing an application called Flynotes - a new digital consent platform. Flynotes analyses a number of factors, including the patient’s background, to deliver personalised risks and benefits. Flynotes aims to be the go-to solution for consent in healthcare. .
  • Nexus Labs (Surgical Teaching) — Nexus Labs is an interactive learning resource for medical students.
Show all investments...

Mercia Fund Managers
VC Fund · Henley In Arden, Warwickshire, United Kingdom · 13 investments in Europe Medical startups

Mercia Asset Management provides equity and debt to UK businesses with growth ambition. We are your investment partners from scale-up to exit.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States, Hungary

Investor stats

  • Total investments: 133
  • Round size: Seed $196k–$2M; Series A $2M–$14M
  • Lead/follow: 67% lead, 33% follow
  • Last fund: May invest from a new fund soon — last raise in 2013

Portfolio highlights

  • 4D Medicine
  • Adludio — Adludio is the AI-powered platform that delivers interactive mobile advertising. By using data to design your ad creative, and algorithms to optimize your campaigns, Adludio makes sure you win the battle for brand attention.
  • Role Mapper Technologies — Automate and transform how you design and manage job descriptions across your organisation. Hire, retain and grow an inclusive and diverse workforce with AI powered Intelligent Job Design.
Show all investments...

Karista
VC Fund · Paris, Ile-de-France, France · 13 investments in Europe Medical startups

Karista is an early-stage venture capital firm created in 2001 investing in Health, Digital, Tech, and NewSpace.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Health Care
  • Stage:Seed, Series A, Series B
  • Geography: France, United States, Finland

Investor stats

  • Total investments: 144
  • Round size: Seed $713k–$6.6M; Series A $1.2M–$15M; Series B $2.5M–$43M
  • Lead/follow: 16% lead, 84% follow

Portfolio highlights

  • CYSEC — Secure your sensitive data in the cloud and in the edge with ARCA Trusted OS and open the door to innovation with confidential computing.
  • Stootie — Stootie is a buyer-focused classifieds platform. It's mobile. It's local. And it's quick. Really quick!This is the tool you use to get that phone power outlet you forgot when you're working in a Starbucks. Or pretty much anything else. Anywhere. Anytime.The keywords of Stootie are : marketplace, P2P business, local,mobile, realtime, platform.Stootie is currently available on iOS and Android.
  • Exotrail — Exotrail is an end-to-end space mobility operator. Our mission is to enable small satellites to move in space, optimise their deployment, increase their service performance, and reduce space pollution.
Show all investments...

Almi Invest
VC Fund · Stockholm, Stockholms Lan, Sweden · 13 investments in Europe Medical startups

Almi Invest is Sweden’s most active early-stage venture capital firm, investing in scalable startups across Sustainability, Industry, Tech, and Life Science.We invest from pre-seed to Series A, always co-investing with independent private investors to accelerate innovation and long-term success. Our portfolio spans sustainable solutions,industrial innovation, deep tech, SaaS, and life science, supporting startups that drive economic and environmental progress.With €430 million under management and over 1,000 investments since 2009, we have backed leading companies like MIPS, Tobii, and Neo4j, with notable exits to Google, Apple, Microsoft, and Qlik.Beyond capital, we offer engaged ownership, providing strategic guidance, active board participation, and access to an extensive investor network.Almi Invest is part of the Almi Group and is funded by the European Regional Development Fund, Almi AB, and regional partners.

Show more...

Investment focus

  • Industry: Software, Health Care, Information Technology
  • Stage:Seed, Pre-Seed
  • Geography: Sweden, United States, Ukraine

Investor stats

  • Total investments: 263
  • Round size: Seed $174k–$2.2M; Pre-Seed $236k–$1.3M
  • Lead/follow: 31% lead, 69% follow
  • Last fund: Likely still investing — fund raised in 2024

Portfolio highlights

  • Indevex AB — Indevex is a science-based and privately owned biotech company from Sweden. A natural and reliable partner, providing evidence based natural nutrition concepts based on the patented NGC™ Formula.
  • Xaga Surgical — Xaga Surgical aims to minimize the risk of infections by inventing safer medical needles.
  • Inhalation Sciences — The PreciseInhale patented aerosol generation R&D platform delivers respirable dry powder aerosols from preclinical cell studies all the way through to human clinical trials, significantly accelerating drug development timelines. The platform’s one-animal-at-a-time system requires just milligrams, not grams of costly test substance for a fullPK study and delivers high-resolution lung data of, typically, <10% SD. We carry out Contract Research for novel and generic inhalation drug developers, toxicology and environmental research institutes and university research institutes in the inhalation and aerosolization field.
Show all investments...

M Ventures
VC Fund · Amsterdam, Noord-Holland, The Netherlands · 12 investments in Europe Medical startups

Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by greatentrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Seed
  • Geography: United States, United Kingdom, Switzerland

Investor stats

  • Total investments: 163
  • Round size: Seed $2.4M–$21M; Series A $5.2M–$45M; Series B $15M–$100M
  • Lead/follow: 39% lead, 61% follow

Portfolio highlights

  • CellFE — We transform the way cell therapies are manufactured to enable affordable advanced treatments for all.
  • UNISERS — Developing solutions for Universal Contamination Analysis. Working with cutting edge technologies to revolutionize contamination control.
  • Polaris Electro-Optics — Polaris Electro-Optics empowers integrated photonics for communications and computation.
Show all investments...

Jonathan Milner
Angel · Cambridge, Massachusetts, United States · 12 investments in Europe Medical startups

Having worked in the life sciences industry for over ten years as an academic researcher, Jonathan identified the market opportunity for supplying high quality antibodies to support protein interaction studies and, in 1998, founded Abcam with David Cleevely and Professor Tony Kouzarides. Jonathan is a Non-Executive Director of Horizon DiscoveryGroup plc, The Evolution Education Trust, GeoSpock Ltd and Sydicate Room Group Ltd. He is also Chairman of Axol Bioscience Ltd, PhoreMost Ltd, Repositive Limited, Definigen Limited and Cambridge Allergy Ltd. Jonathan holds an executive director position at Meltwind Limited, being a designated member of Meltwind Advisory LLP. Jonathan is an experienced entrepreneur and investor and is passionate about supporting UK life science and high-tech start-ups. He has provided considerable investment and support to over 30 companies and has assisted three AIM IPOs.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Seed, Series A, Series B
  • Geography: United Kingdom, United States, Spain

Investor stats

  • Total investments: 61
  • Round size: Seed $537k–$16M; Series A $4.1M–$50M; Series B $1.6M–$56M
  • Lead/follow: 20% lead, 80% follow

Portfolio highlights

  • Nuclera — Nuclera makes biology accessible through desktop enzymatic protein and gene synthesis. Nuclera has since grown to fifty-seven employees across two continents as the Company delivers on its founders’ vision to make biology accessible to everyone through desktop bioprinting. With desktop bioprinting, researchers and scientists will be empowered totake control of biology through streamlined access to a next-day supply of proteins and genes.
  • 52 North Health — At 52 North we are developing fully-integrated clinical, AI and medical-device based systems.
  • Constructive Bio — We place non-canonical amino acids at precise positions in proteins and peptides to create therapeutics with new properties, then manufacture them through fermentation.
Show all investments...

Wellcome Trust
VC Fund · London, England, United Kingdom · 12 investments in Europe Medical startups

Wellcome Trust is a medical research charity that funds research that aims to protect and improving human and animal health. It focuses on the fields of public engagement, investments, innovation, humanities, and social science. It was founded in 1936 and headquartered in London, England.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Grant, Series C
  • Geography: United States, United Kingdom, France

Investor stats

  • Total investments: 115
  • Round size: Grant $1.3M–$8M; Series C $10M–$127M
  • Lead/follow: 37% lead, 63% follow
  • Last fund: May invest from a new fund soon — raised $319M in 2018

Portfolio highlights

  • Cultivarium — We develop molecular, hardware and software tools to accelerate the adoption of microbes for beneficial biotechnologies.
  • Lario Therapeutics — Lario Therapeutics is a biopharmaceutical firm that develops precision therapeutics for epilepsy and neurological disorders.
  • Ineffable Intelligence — Ineffable Intelligence develops machine learning systems that learn through interaction and experience. The company works on reinforcement learning approaches that allow models to improve by trial and error rather than relying on large human-generated datasets. Its core work centers on building a “superlearner,” a system designed to generateknowledge and skills by engaging with simulated or real environments.The organization develops algorithms and computational frameworks that support autonomous learning, experimentation, and decision-making processes. Its efforts involve designing AI models that can adapt, refine behavior, and solve complex problems through continuous feedback loops. The company’s research aims to expand how AI systems acquire knowledge and apply it across different domains.
Show all investments...

Cambridge Innovation Capital
VC Fund · Cambridge, Cambridgeshire, United Kingdom · 12 investments in Europe Medical startups

As a team, we have a passion for science and its potential to drive change. Through our expertise and our position in one of the country's most powerful science and technology ecosystems, we're able to identify and support the most promising entrepreneurs in knowledge intensive businesses and help them achieve their vision.With our financial backing and expert guidance, we're excited to enable the pioneers in life sciences and deep tech to create world-leading companies whose unique ideas bring financial success and global impact.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Seed
  • Geography: United Kingdom, United States, Ireland

Investor stats

  • Total investments: 97
  • Round size: Seed $3.9M–$23M; Series A $2M–$73M; Series B $8.5M–$65M
  • Lead/follow: 36% lead, 64% follow
  • Last fund: Likely actively investing — fund raised in 2025

Portfolio highlights

  • Immutrin — Immutrin is a biotechnology company developing next‑generation antibody therapies designed to clear systemic amyloid deposits and reverse amyloidosis, this company lead asset targets ATTR cardiomyopathy, a severe and progressive form of amyloidosis, and its antibody represents a potential best‑in‑class treatment engineered to selectively andspecifically remove established amyloid fibrils.
  • Trent AI — Trent AI creates AI applications and agent security management software. It aids in risk assessment and mitigation in systems utilizing autonomous or semi-autonomous software agents. The company's technology monitors agent activity across APIs, tools, and workflows. It continuously assesses security posture via iterative scanning andcontextual understanding of system architectures.
  • Forefront RF — Forefront RF tunable duplexer technology expands the accessibility of all mobile devices by unlocking SDR capabilities in the RFFE front end.
Show all investments...

Northstar Ventures
VC Fund · Newcastle Upon Tyne, Newcastle upon Tyne, United Kingdom · 12 investments in Europe Medical startups

Northstar Ventures invests venture capital in early and later stage, high growth companies tackling global challenges, focusing on climate tech and healthy ageing.

Show more...

Investment focus

  • Industry: Software, Health Care, E-Commerce
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States, Indonesia

Investor stats

  • Total investments: 189
  • Round size: Seed $39k–$1.8M; Series A $851k–$9.7M
  • Lead/follow: 28% lead, 72% follow
  • Last fund: Likely actively investing — fund raised in 2024

Portfolio highlights

  • H2CHP — H2CHP's Free Piston Engine Technology enables your transition to green energy with the reliability & confidence of fuel flexibility.
  • NunaBio — NunaBio operates as a privately-owned specialist DNA development company. NunaBio engaged in CRO (Contract Research Organizations) and CDMO (Contract Development and Manufacturing Organisation) activities.
  • Moralbox
Show all investments...

Development Bank of Wales
VC Fund · Cardiff, Cardiff, United Kingdom · 12 investments in Europe Medical startups

Development Bank of Wales is an independent company, providing commercial funding to Welsh SMEs. They invests private and public funds, including EU funds.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Seed, Debt Financing
  • Geography: United Kingdom, Australia, United States

Investor stats

  • Total investments: 211
  • Round size: Seed $327k–$3.7M; Debt Financing $18k–$2M
  • Lead/follow: 58% lead, 42% follow
  • Last fund: May invest from a new fund soon — raised $25M in 2018

Portfolio highlights

  • Forth — Forth are a group of clinical and digital experts who are passionate about healthcare. They’re part of a new breed of digital healthcare companies who are transforming people’s relationship with their health by using technology to give them more information and help them gain greater control.
  • enModus — Experience the thrill of competing against other players in online casino tournaments! These events offer a unique opportunity to showcase your skills and
  • Antiverse — Designing biologics for 100 challenging targets
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Wellington Partners
VC Fund · Munich, Bayern, Germany · 12 investments in Europe Medical startups

Wellington Partners is a venture capital firm that invests in technology and life sciences companies, focusing on Digital Media, Software, Electronics & Photonics, Resource Efficiency, and Biotech/Life Sciences. It is committed to providing outstanding entrepreneurs with the necessary resources to fund their strategies. We typically leadfinancing rounds ranging from € 0.5 million to € 20 million. Depending on the maturity of the company, its own commitment can go as high as € 15 million.Wellington was established in 1998 and has offices in Munich, London, and Zurich.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series A, Series B
  • Geography: Germany, United States, United Kingdom

Investor stats

  • Total investments: 192
  • Round size: Series A $3.1M–$33M; Series B $6.7M–$55M
  • Lead/follow: 30% lead, 70% follow
  • Last fund: May invest from a new fund soon — raised $222M in 2019

Portfolio highlights

  • nyra health — myReha is an artificial intelligence and evidence-based neurological research tablet app that offers a revolutionary form of therapy. myReha was founded in 2020 and was headquartered in Vienna, Austria.
  • UroMems — The device is developing an active implantable medical device based on the cutting edge technologyl in the field of embedded systems and micro-technologies for the development of its products.
  • Heliatek — As the technology leader in organic photovoltaics, Heliatek develops, produces and distributes industrial-grade organic PV solar solutions for virtually any building surface (horizontal, vertical, curved, rigid, and flexible). Heliatek stands for energy solutions designed for various traditional and never been possible before applications based onits unique features – it is ultra-light, flexible and truly green. HeliaSol® is a ready-to-use solution, ideal for retrofitting on existing building structures. HeliaFilm® is tailor-made solar film for companies in the building and construction material industry, to integrate into their façade or roof system products. Heliatek currently employs about 160 people at the Dresden and Ulm locations in Germany.The Free State of Saxony, the Federal Republic of Germany, and the European Union funded research and development, as well as the installation of the production technology.
Show all investments...

KfW
VC Fund · Frankfurt, Hessen, Germany · 11 investments in Europe Medical startups

KfW gives impetus to economic, social and ecological development worldwide. As a promotional bank under the ownership of the Federal Republic and the Länder (federal states), it offers support to encourage sustainable improvement in economic, social, ecological living and business conditions, among others in the areas of small and medium-sizedenterprise, entrepreneurialship, environmental protection, housing, infrastructure, education finance, project and export finance, and development cooperation.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Health Care
  • Stage:Series A, Series B
  • Geography: Germany, India, Kenya

Investor stats

  • Total investments: 140
  • Round size: Series A $2.2M–$7.7M; Series B $3.3M–$17M
  • Lead/follow: 12% lead, 88% follow

Portfolio highlights

  • Vectoflow — Vectoflow is an innovative company developing fluid-dynamic metrology devices for fluid flow and dynamics measurement. It offers standardized and customized flow measurement technology that measures the static and total pressure, velocity, and angle of attack of a flow. These products are used in motorsport, aviation, turbine machine development,and research sectors.
  • Electrochaea — Electrochaea is commercializing a disruptive, scalable technology to convert electric power into methane, the principal component of natural gas. Using CO2 as a feedstock gas, power can be efficiently converted to renewable natural gas for power storage, for transportation fuels, or for transmission via a natural gas network. The company licensedtechnology from the University of Chicago and is led by the Nidus Partners, a St. Louis investment group specializing in renewable energy. Mich Hein, a Nidus Managing Partner, serves as CEO.Electrochaea has developed a commercially viable and disruptive solution for utility-scale energy storage, grid balancing, and carbon reuse. Their proprietary process converts low-cost and stranded electricity and carbon dioxide into pipeline-grade renewable gas for direct injection into the existing natural gas grid, a conversion process known as “power-to-gas”.
  • CryoTherapeutics — CryoTherapeutics is focusing on the development, demonstration of clinical benefit, and early-stage commercialization of a proprietary cryotherapy system for use in the treatment of coronary artery disease that causes heart attacks. The safety and efficacy of cryoenergy in the cardiovascular system has been demonstrated and CryoTherapeutics intendsto extend the benefits of cryoenergy to the problem of diseased coronary arteries.
Show all investments...

Chalmers Ventures AB
VC Fund · Göteborg, Vastra Gotaland, Sweden · 11 investments in Europe Medical startups

We are a leading tech investor & venture builder in the Nordics. Taking deep tech from lab to market.WELCOMEINVESTMENTS

Show more...

Investment focus

  • Industry: Software, Biotechnology, Health Care
  • Stage:Pre-Seed, Seed
  • Geography: Sweden

Investor stats

  • Total investments: 169
  • Round size: Seed $289k–$2.7M; Pre-Seed $5k–$183k
  • Lead/follow: 48% lead, 52% follow

Portfolio highlights

  • Embedl AB — Efficient Deep Learning by Deep Learning model optimization
  • Repli5 — Enabling autonomous vehicles with synthetic data. We automate the creation of synthetic data and digital twins.
  • Detecht — Looking for a motorcycle app for your upcoming trips? Download Detecht with built-in GPS, Navigation, Route suggestions and Crash Detection on App Store or Google Play Store
Show all investments...

Catapult Ventures
VC Fund · Leicester, Leicester, United Kingdom · 11 investments in Europe Medical startups

The team behind Catapult Ventures are among the most experienced venture capital investors in the UK.Their experience spans a range of sectors from healthcare and pharmaceuticals to luxury consumer brands, manufacturing and software, as well as all stages: from start-ups and pre-revenue IP developers to company floatation and billions of poundsin revenue. Their administration team is equally experienced with each member having more than 10 years experience in a venture capital environment.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States, Israel

Investor stats

  • Total investments: 104
  • Round size: Seed $150k–$5.6M; Series A $1.6M–$26M
  • Lead/follow: 25% lead, 75% follow
  • Last fund: May invest from a new fund soon — last raise in 2018

Portfolio highlights

  • Rinicare — Rinicare is Lancaster-based SME that offers innovative technology solutions for healthcare applications.
  • Pickle Robot — We make robots that unload trucks without retrofitting the warehouse
  • Anello Photonics — Anello Photonics is founded by pioneers in silicon photonics and inertial navigation. The patented Anello SiPhOG gyroscope offers an affordable mass-market sensor with true Optical Gyroscope performance. The company is headquartered in Silicon Valley and funded by leading venture capital firms.
Show all investments...

CDP Venture Capital
VC Fund · Rome, Lazio, Italy · 11 investments in Europe Medical startups

CDP Venture Capital Sgr - National Innovation Fund aims to make venture capital a cornerstone of the country's economic development and innovation, creating the conditions for an overall and sustainable growth of the venture capital ecosystem.

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Seed, Series A
  • Geography: Italy, United States, United Kingdom

Investor stats

  • Total investments: 228
  • Round size: Seed $488k–$8.3M; Series A $3.3M–$17M
  • Lead/follow: 41% lead, 59% follow
  • Last fund: Likely still investing — raised $197M in 2021

Portfolio highlights

  • Radical Storage — Find your closest luggage storage and enjoy your journey until the very end!
  • Mela Works — Manage your work site with Mela, and generate logbooks and reports with one click. Download Mela now!
  • Multiverse Computing — World leaders in quantum computing for the financial industry. The first quantum & quantum-inspired toolbox for finance.
Show all investments...

Seventure Partners
VC Fund · Paris, Ile-de-France, France · 10 investments in Europe Medical startups

Seventure Partners is a French venture capital firm targeting in Tech/Digital and Life Sciences companies. It funds innovation and participates in the entrepreneurial adventure, alongside entrepreneurs and sharing their passion.Founded in 1997, Seventure Partners is one of the European leaders in venture capital, with € 1 billion undermanagement as of December 31, 2023. It is an active partner of innovative companies that, according to the management team, show strong growth potential and evolving in two fields of activity: Digital Technologies and Life Sciences. With more than 20 employees, including some 15 investors, Seventure Partners has a proven track record and in-depth expertise in technology, entrepreneurship, and various private equity operations.Seventure's goal is to identify and support the development of tomorrow's European leaders in order to accelerate their growth. To do this, the firm provides entrepreneurs with the expertise, networks, and know-how of its internal team of investors.The different funds/verticals on which Seventure Partners are focusing on today: - Life Sciences : Biotech, Healthcare, Nutrition - Tech/Digital : B2B SaaS, Fintech, Retailtech, Cybersecurity - Sports & Wellbeing - Blue Economy

Show more...

Investment focus

  • Industry: Biotechnology, Software, Health Care
  • Stage:Series A, Series B
  • Geography: France, United States, Germany

Investor stats

  • Total investments: 213
  • Round size: Series A $3.1M–$24M; Series B $3.3M–$65M
  • Lead/follow: 36% lead, 64% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Otoqi — Otoqi is a vehicle delivery platform that develops connected services and logistics solutions for the automotive professionals.
  • Karmen — Karmen offers revenue-based financial solutions such as venture capital and loans to accelerate business growth for SaaS companies.
  • Flexvelop — Flexvelop combines financial technology with circular economy to add innovative values to the core function of equipment funding.Local vendors and online-shops integrate Flexvelop as a seamless embedded payment option. Business customers are now able to #flex new equipment per click right at the point of sale. Insurance is already covered, andour customers have now the weekly option, to buy- or return their equipment, easily. This enables a new world of worry-free and flexible business growth.We #flex business equipment from €300 up to €20.000 per item; e.g. coffee-machines, laptops, gym- or dental-equipment,... anything you need for your business.NEXT GENERATION PAYMENTS + Technological Innovation: fully automatic embedded payment option + Economical Innovation: optionality (rent/buy/return) + insurance included + Ecological Innovation: sustainability (contributing to a circular economy) = Enabling worry-free flexible business developmentForget renting. Forget leasing. Grow smart - flex it!
Show all investments...

Oxford Capital
VC Fund · Oxford, Oxfordshire, United Kingdom · 10 investments in Europe Medical startups, 6 in the past 12 months

Helping individuals and institutions invest in Venture Capital, Infrastructure and Media companies since 1999.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States, France

Investor stats

  • Total investments: 141
  • Lead/follow: no public data

Portfolio highlights

  • Egregious — Egregious is an advanced research & intelligence lab established to defend humans from AI and provides narrative intelligence solutions across the public and private sectors to protect organisations and online users from malign influence using AI-driven data acquisition, insights, and engagement.
  • Arcube — We make sure all travellers, frequent and infrequent, make the most of travel loyalty programs, using our data-driven approach, airlines can understand their customers and provide hyper-personalised offerings to boost value and retention.Arcube uses a data-driven approach to make the most of airline loyalty programs for both frequent andinfrequent flyers. Our software allows airlines to understand their customers and provide hyper-personalised offerings to boost value and retention at no extra cost to the airline.
  • FinCrime Dynamics — Our mission is to help make the world’s financial system safer through rapid deployment of effective AI for financial crime analytics, enabled by enriched synthetic data that captures the dynamics of fraud and money laundering and loads them into tailor-made scenarios that explore diverse threats that financial organisations are exposed to.Thisgoal has taken us to the forefront of Synthetic Data and Fincrime Analytics, and we are proud to have in our team people that have helped shape the state-of-the-art of these fields.Keywords: Finacial services, AML, Synthetic Data, Fintech, Machine learning, Big data, Simulation, Fraud Analytics, Compliance
Show all investments...

European Investment Bank
VC Fund · Luxembourg, Luxembourg, Luxembourg · 10 investments in Europe Medical startups

The European Investment Bank (EIB) offers lending, borrowing, and treasury services primarily within the European Union. It provides project loans for public and private sectors, loans to banks and intermediaries, structured finance products, guarantees, and securitization instruments for debts. Additionally, EIB offers equity and fund investmentproducts, including infrastructure and environmental funds, as well as venture capital funds. EIB also supports microfinance and risk-sharing finance for research and innovation, and provides technical expertise for sustainable energy projects. Its services include infrastructure advisory, urban development support, guarantees for transport infrastructure, and funding for public-private partnerships and small- to medium-sized enterprises. The bank serves various sectors, including transportation, energy, health, education, and agriculture.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Energy
  • Stage:Debt Financing, Post-IPO Debt
  • Geography: France, Germany, The Netherlands

Investor stats

  • Total investments: 294
  • Round size: Post-IPO Debt $7.7M–$658M; Debt Financing $13M–$400M
  • Lead/follow: 78% lead, 22% follow

Portfolio highlights

  • IPT PowerTech — IPT PowerTech coverage, coupled with our extensive expertise in supply chain management, field implementation, and power systems, has made us one of the most capable companies in handling the most complicated and versatile projects in the MEA region and its neighboring countries.
  • Interconnect Malta — Interconnect Malta is a government organization that develops and implements energy infrastructure projects.
  • NVision Imaging Technologies — NVision Imaging Technologies is leveraging advances in quantum physics to enable the first routine, convenient and affordable use of Magnetic Resonance Imaging (MRI) for assessing early patient response to cancer treatment at the metabolic level.
Show all investments...

Calm/Storm VC
VC Fund · Vienna, Wien, Austria · 10 investments in Europe Medical startups

Calm/Storm is an exclusive founder network and venture capital firm. We invest in purpose driven founders changing our life & health for the better. Headquartered in Vienna, Austria we invest in early-stage companies all over Europe and the US. We focus on the pre-seed and seed stages but also invest up to Series A.

Show more...

Investment focus

  • Industry: Health Care, Wellness, Software
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United Kingdom, Germany, Austria

Investor stats

  • Total investments: 118
  • Round size: Seed $1.1M–$7.3M; Pre-Seed $478k–$2.7M; Series A $6M–$18M
  • Lead/follow: 8% lead, 92% follow
  • Last fund: May invest from a new fund soon — raised $23M in 2020

Portfolio highlights

  • thymia — We use video games based on Neuropsychology alongside analyses of video and speech to make mental health assessments smart, starting with depression.Our online platform empowers clinicians so they can assess depression faster, more accurately and objectively. Our multi-modal depression recognition and tracking system allows us to find the righttreatment in weeks instead of years and we make the entire process enjoyable for the patient.
  • doctorly — doctorly is a digital medical infrastructure platform. We have a regulated, cloud powered, fully centralised, practice management platform for doctors, a fully connected health app for patients, and an integration platform for the wider industry to natively connect their tools & workflows directly with our doctors & patients.We are backedby amazing investors and driven by a desire to make positive and meaningful changes to the healthcare industry internationally.
  • Bea Fertility — Bea Fertility is a monthly subscription program that provides users with at-home fertility treatment and ovulation tracking.
Show all investments...

Western Development Commission
VC Fund · Ballaghaderreen, Roscommon, Ireland · 10 investments in Europe Medical startups

Supporting communities to grow, investing in businesses to scale and planning for the future of the western region.

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Biotechnology
  • Stage:Seed, Series A
  • Geography: Ireland, United States

Investor stats

  • Total investments: 43
  • Round size: Seed $642k–$3.7M; Series A $2.2M–$11M
  • Lead/follow: 16% lead, 84% follow

Portfolio highlights

  • Ovagen — Ovagen is a biotechnology company that has developed the process of producing germ free (GF) chicken eggs and GF birds in commercial quantities for use primarily in the pharmaceutical industry. Ovagen can also provide a Contract Research Service and has extensive expertise in SPF poultry & rodent housing & husbandry, in specific poultry& rodent research technologies to GMP standards and in avian transgenics.
  • Peroptyx — Peroptyx is a platform that provides managed solutions for machine learning. At Peroptyx, they have assembled and pre-screened a qualified network of data evaluators across the globe. They strategically match ideal evaluators with each product to ensure authentic experiences through consistency and appropriate real-world contexts.
  • Galway Biomedical — Galway Biomedical partners with global medical device companies to bring complex braided devices from early concept through to full-scale production.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
MIG Capital
VC Fund · München, Bayern, Germany · 10 investments in Europe Medical startups

MIG Capital is one of the leading German VC Investors. We invest in European Deep Tech and Life Sciences from early to late stage (Seed, Series A, and beyond). We use investments to shape a better tomorrow, today. Our team currently manages 17 MIG public venture capital funds regulated by BaFin, the German financial markets authority. These fundsoperate with more than EUR 1.2 billion capital committed by >60,000 private investors across Germany and Austria.Today, our portfolio consists of 30 companies.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B
  • Geography: Germany, France, Austria

Investor stats

  • Total investments: 93
  • Round size: Series A $2.2M–$28M; Series B $1.6M–$54M
  • Lead/follow: 45% lead, 55% follow
  • Last fund: May invest from a new fund soon — raised $70M in 2014

Portfolio highlights

  • AMSilk — AMSilk produces and distributes high-quality silk biopolymers for use in textile products, medical devices, and cosmetics.
  • Look Up Space — Lookup space is the next global leader for space safety, security and sustainability
  • ASTRA Therapeutics — Astra - Therapeutics
Show all investments...

GO CAPITAL
VC Fund · Rennes, Bretagne, France · 10 investments in Europe Medical startups

GO Capital is an independent management company and a major player in regional Seed and Venture Capital since 2003. With offices in Brittany, Pays de la Loire, Normandy, Centre-Val de Loire and the South of France, GO Capital contributes to the financing of responsible innovation in these regions. With a team of investors with complementarysectoral experience, we have a solid track-record in DeepTech. GO Capital has nearly 400 million euros under management, and mainly finances technology leaders in the digital and healthcare sectors and in the industry of the future.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Health Care
  • Stage:Seed, Series A
  • Geography: France, Canada, Israel

Investor stats

  • Total investments: 130
  • Round size: Seed $516k–$6.6M; Series A $2.1M–$10M
  • Lead/follow: 37% lead, 63% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • Episto — Episto helps you collect ultra-authentic insights from your targets, anywhere in the world, simply and instantly
  • AISPRID — AISPRID is a robotic company that manufactures autonomous robots for soft fruit picking.
  • Axomove — Axomove is an e-health app that specializes in video physical exercises.
Show all investments...

AlbionVC
VC Fund · London, England, United Kingdom · 10 investments in Europe Medical startups

AlbionVC supports visionary founders and technologies with long-term capital and scale-up know-how. Founded in 1996, it was amongst the first to back leading global success stories such as Booking.com, Egress, Quantexa and Oviva. With £1bn in AUM and over 100 exits successfully realised, it funds venture breakthroughs that drive real outcomes forfounders, investors and society. AlbionVC is the technology investment arm of Albion Capital Group, which is authorised and regulated by the Financial Conduct Authority. For more information please visit: https://albion.vc/

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Series A, Seed
  • Geography: United Kingdom, United States, France

Investor stats

  • Total investments: 159
  • Round size: Seed $2.2M–$13M; Series A $3.8M–$20M
  • Lead/follow: 42% lead, 58% follow

Portfolio highlights

  • Oviva — Oviva is digitizing the treatment of type 2 diabetes and obesity through a unique behavior change platform.They have developed unique, personalised behaviour change programmes that combine smartphone app and learning portals to support dietitian-led behaviour change for conditions such as type 2 diabetes and complex obesity. Their approach allowspatients to achieve a better health outcome without having to attend clinic appointments, whilst saving health systems significant sums by preventing the development of complications related to these health conditions.Oviva was founded in 2013 and is based in London, England.
  • uMotif — uMotif provides the most modern eCOA/ePRO and eConsent platform designed to power clinical and real-world research.
  • Ophelos — Flexible repayments, with an empathetic approach. Discover how we can help you get debt-free on your terms and timescales.
Show all investments...

APEX Ventures
VC Fund · Vienna, Wien, Austria · 10 investments in Europe Medical startups

APEX Ventures is an early-stage venture capital fund that invests in start-ups grounded in unique and protectable technology. They provide support and resources and aims to develop their start-ups in their respective field. Their initial focus areas include digital media, business intelligence, cybersecurity, fintech, and the future of work.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Health Care
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Germany, United Kingdom, Austria

Investor stats

  • Total investments: 57
  • Round size: Seed $1.3M–$8M; Pre-Seed $511k–$3M; Series A $5.2M–$28M
  • Lead/follow: 30% lead, 70% follow

Portfolio highlights

  • Quibim — Quibim builds AI tools that turn MRI, CT and PET data into actionable predictions for hospitals and biopharma. Trusted in 230+ centers worldwide.
  • Robeaute — Redesigning the future of neurosurgery by creating the new standard device that will provide surgeons with seamless access to delicate areas of the brain parenchyma and with real-time data.
  • OroraTech — From safeguarding forests and ecosystems to protecting communities and critical assets, OroraTech's advanced technology and reliable insights address challenges, mitigate risks, and drive meaningful impact.
Show all investments...

Newable Private Investing
VC Fund · London, England, United Kingdom · 10 investments in Europe Medical startups

Newable: Helping over 20,000 businesses thrive annually with tailored financial products, advice, and flexible workspace solution

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States

Investor stats

  • Total investments: 103
  • Round size: Seed $196k–$3.9M; Series A $1.3M–$5.2M
  • Lead/follow: 22% lead, 78% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Zentraxa — NATURE ENGINEERED FOR PURPOSE Through millions of years of evolution, nature has found solutions to the most difficult problems. Inspired by the diversity of nature, we precision engineer bespoke biomaterials to meet the toughest challenges across
  • Elemendar — Elemendar is building Artificial Intelligence that reads cyber threat reports by humans and turns them into industry-standard structured information.
  • NuVision — NuVision™ is a spin-out company from the University of Nottingham, incorporated July 2014. The company was established to commercialise high quality and affordable biotherapies for treating ‘front of the eye’ disease and trauma. Dr Andrew Hopkinson, the Principal Research Fellow in Academic Ophthalmology, Division of Clinical Neuroscience at theUniversity of Nottingham, founded NuVision™. The business is co-owned by the founders, Dr Andrew Hopkinson (Chief Scientific Officer), Professor Harminder Dua (co-founder), the directors Mr Byran Lister (CEO) and Dr Helen Shaw (Chairman), and the University of Nottingham.
Show all investments...

Meusinvest (Noshaq)
VC Fund · Liège, Liege, Belgium · 10 investments in Europe Medical startups

Noshaq offers financial services to help businesses develop.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Seed
  • Geography: Belgium, France, Germany

Investor stats

  • Total investments: 76
  • Round size: Seed $137k–$6M; Series A $3.3M–$16M
  • Lead/follow: 9% lead, 91% follow

Portfolio highlights

  • TrustUp — TrustUp is the home contractors platform, connects homeowners with verified quality home improvement.
  • Le Fourgon — Le Fourgon provides contained drinks for home delivery. They offer milk, water, beer, wine, fruit juice, and sodas. They allow customers to have their drinks delivered free of charge during the day.
  • Allegro Biotech — Allegro has developed the world’s-first custom-tailored, durable, biocompatible, anisotropic, regenerative meniscus cartilage, providing immediate support while also leverage the body’s own healing potential to regenerate human cartilage (proliferation and differentiation of fibrochondrocyte cells).
Show all investments...

Atlantic Bridge
VC Fund · Dublin, Dublin, Ireland · 10 investments in Europe Medical startups

Atlantic Bridge is a Growth Equity Firm with a Cross Border Value Add strategy. We invest in deep technology companies in Europe and the US. Our team is made up of successful entrepreneurs and senior technology industry executives and we invest in strong ambitious entrepreneurs and management teams that have the passion and drive to scale up andexploit major growth opportunities. We help our portfolio companies expand and grow internationally through our global platform with our team and offices in London, Dublin, Munich, Paris and Palo Alto.Atlantic Bridge brings together a unique team of technology entrepreneurs, experienced managers, finance professionals, and investment experts. The team contains a wealth of international business experience across Europe, the UK and the US. They have worked together in various capacities for the last 30 years, bringing a true partnership approach to their firm and their investments. Its investors include the founders, leading institutional investors, and private investors with a track record of investment in successful technology companies.Atlantic Bridge has developed a unique and differentiated strategy that focuses on specific technology themes and the implementation of the “Atlantic Bridge Model” for scaling companies internationally. The “Bridge Model” accelerates the scale-up of technology companies in Europe and the US. This approach is highly differentiated and has delivered strong performance results to date.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Analytics
  • Stage:Series A, Series B
  • Geography: United States, Ireland, United Kingdom

Investor stats

  • Total investments: 135
  • Round size: Series A $4.5M–$26M; Series B $10M–$62M
  • Lead/follow: 41% lead, 59% follow
  • Last fund: Likely still investing — raised $88M in 2021

Portfolio highlights

  • Striim — Modern, reliable data integration across your private and public cloud. All in real-time with change data capture and data streams.
  • HyperGrid™ — HyperCloud enables businesses to embrace public clouds and drive their digital transformation via the broadest set of functionalities to discover and plan cloud migrations, optimize costs, secure resource and scale operations in the public cloud. HyperCloud has a unique app-centric, modular approach that enables businesses to scale their cloudmanagement capabilities within a common framework that provides centralized control and management of all private and public clouds and eliminates the need for ongoing training. HyperCloud analytics is powered by its massive database of more than 400 million data points across the major public clouds enabling instantaneous recommendations for optimizing new and existing applications using multi-dimensional analysis of factors such as cost, performance, and compliance. HyperCloud also analyzes past cloud usage to understand customer needs and speed service delivery by eliminating manual processes. As a result, enterprise IT and MSPs can deliver customized services across any private or public cloud, improving business performance while minimizing cloud management complexities.
  • Snowplow — Snowplow gives teams complete flexibility and control over how behavioral data is collected, structured, processed, modeled and stored.
Show all investments...

Portugal Ventures
VC Fund · Porto, Lisboa, Portugal · 9 investments in Europe Medical startups

Verticals:Enterprise, SaaS, Security, Networks, AI, VR/AR, Marketplace, Blockchain, Internet of Things, New materials, Electronics, Robotics, Cleantech, Agrotech, Seatech, Therapeutics, Digital Health, Diagnostics, Innovative Accommodation, Tourist Entertainment Companies, Tour Operators, Wine, Nautical and Equestrian Tourism, Theme ParksMobile, Robotics Founded in 2012, Portugal Ventures is a venture capital firm based in Porto, Portugal. The firm is a part of the Banco Português de Fomento group. The firm seeks to invest in pre-seed, seed and series A stages

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Seed, Pre-Seed
  • Geography: Portugal, United States, France

Investor stats

  • Total investments: 210
  • Lead/follow: no public data

Portfolio highlights

  • AddVolt — AddVolt is a technology based company that tackles markets where there is a high potential for diesel costs reduction through the generation of solar and kinetic energy, while other secondary savings are generated (e.g. maintenance).
  • Hephaesnus — Hephaesnus is an industrial technology startup dedicated to the development of products and technologies for forest firefighting.
  • Floating Particle — Floating Particle is a technology and innovation company that drives an innovative solution for waste management and clean energy. Floating Particle specializes in IoT, Big Data and Machine Learning to provide cutting-edge technology to the customers.
Show all investments...

Italian Angels for Growth
VC Fund · Milan, Lombardia, Italy · 9 investments in Europe Medical startups

IAG is an angel investor network that offers access to its affiliates to early-stage venture opportunities. Its members to date have deployed over 22 million Euros to support 41 startups in the series seed/series A stage in many verticals, among which: Medtech, SAAS, e-commerce, Fintech, and high tech at large. Every investment opportunityat IAG is vetted by a professional team together with expert members of the group. Once invested, the company receives the support of up to two Investment champions, who bring their expertise to the table and help them succeed.

Show more...

Investment focus

  • Industry: Software, E-Commerce, Health Care
  • Stage:Seed, Angel, Series A
  • Geography: Italy, United States, United Kingdom

Investor stats

  • Total investments: 96
  • Lead/follow: no public data

Portfolio highlights

  • ALKemist Bio — ALKemist Bio is a biotech startup developing next-generation T cell therapies that target ALK-positive cancers. By reprogramming the immune system, the company aims to overcome resistance and deliver more effective, lasting treatments for solid tumors.
  • Rubedo Life Sciences — Rubedo Life Sciences is the Premier Longevity Company. Rubedo discovers and develops medicines to keep you biologically young.
  • Restorative Neurotechnologies — Siamo un'azienda di dispositivi medicali certificati per la riabilitazione cognitiva ed il trattamento di disturbi cognitivi post ictus.
Show all investments...

Vesalius Biocapital Partners
VC Fund · Strassen, Luxembourg, Luxembourg · 9 investments in Europe Medical startups

Vesalius Biocapital Partners invests in companies active in human health through venture capital funds raised since 2007. They have contributed to developing 20 companies since inception.With more than € 150 million under management in two funds. Vesalius Biocapital Partners plays the role of lead investor in the large majority of its financingrounds.Their companies are based in Europe allowing easy interaction with management.They invest in all stages of development and do not shy away from relatively early-stage projects with a sound proprietary technology and corresponding IP, unique team skills and a clear competitive edge based on solid data.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: Belgium, Germany, France

Investor stats

  • Total investments: 59
  • Round size: Series A $3.8M–$20M; Series B $4.4M–$27M; Series C $6.9M–$100M
  • Lead/follow: 42% lead, 58% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • Caresyntax — Caresyntax is the only enterprise-scale surgical data solution you need to make surgery smarter, safer, and more profitable.
  • ENYO Pharma — ENYO Pharma is a biopharmaceutical company incorporated in Jan, 2014, by four scientists of the Infectiology Research Center in Lyon, France, and three seeding partners (2 privates and 1 public).The company is based in the Infectiology Center of Lyonbiopôle in Lyon, France and maintains tight collaborations with the seminal Inserm team and theBSL4 laboratory Inserm-Jean Mérieux.ENYO Pharma has licensed several Inserm patents issued from the discoveries of the founding scientists and developed a unique platform for the identification of intracellular therapeutic targets and molecules.The company is developing treatments against the most important viruses and is thriving to become a global leader in anti-virals. Research and Development is currently focused on human infecting viruses, with the first two programs being dedicated to the treatment of severe and seasonal flu and chronic hepatitis B. The company plans to conduct its molecules to Phase II clinical trials.
  • Inflammatix — Inflammatix develops rapid point of care diagnostic tests by reading the immune system, and resolves major clinical health challenges.
Show all investments...

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Medical Investors in Europe investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 48,091 investors investing in Europe Medical startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists